Agilent Technologies cash flow statement
In fiscal 2025, Agilent Technologies's operations generated $1.56bn of cash; it spent $407m on capital projects, leaving free cash flow of $1.15bn. It returned $282m in dividends and $425m through buybacks.
Cash flow statement
| Fiscal year | 2009Oct 2009 | 2010Oct 2010 | 2011Oct 2011 | 2012Oct 2012 | 2013Oct 2013 | 2014Oct 2014 | 2015Oct 2015 | 2016Oct 2016 | 2017Oct 2017 | 2018Oct 2018 | 2019Oct 2019 | 2020Oct 2020 | 2021Oct 2021 | 2022Oct 2022 | 2023Oct 2023 | 2024Oct 2024 | 2025Oct 2025 | LTMJul 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 408 | 718 | 1,260 | 1,228 | 1,152 | 731 | 512 | 793 | 889 | 1,087 | 1,021 | 921 | 1,485 | 1,312 | 1,772 | 1,751 | 1,559 | 1,609 |
| Depreciation and amortisation | 162 | 202 | 253 | 301 | 372 | 384 | 253 | 246 | 212 | 210 | 238 | 308 | 321 | 317 | 271 | 257 | 288 | 271 |
| Stock-based pay | 71 | 66 | 72 | 74 | 85 | 96 | 54 | 58 | 60 | 70 | 72 | 83 | 110 | 125 | 111 | 129 | 128 | 132 |
| Capital spending | 128 | 121 | 188 | 194 | 195 | 205 | 98 | 139 | 176 | 177 | 155 | 119 | 188 | 291 | 298 | 378 | 407 | 342 |
| Free cash flow | 280 | 597 | 1,072 | 1,034 | 957 | 526 | 414 | 654 | 713 | 910 | 866 | 802 | 1,297 | 1,021 | 1,474 | 1,373 | 1,152 | 1,267 |
| Free cash flow after stock pay | 209 | 531 | 1,000 | 960 | 872 | 430 | 360 | 596 | 653 | 840 | 794 | 719 | 1,187 | 896 | 1,363 | 1,244 | 1,024 | 1,135 |
| Dividends paid | — | 0 | 0 | 104 | 156 | 176 | 133 | 150 | 170 | 191 | 206 | 222 | 236 | 250 | 265 | 274 | 282 | 286 |
| Share buybacks | 157 | 411 | 497 | 172 | 900 | 200 | 267 | 434 | 194 | 422 | 723 | 469 | 788 | 1,139 | 575 | 1,150 | 425 | 380 |
| Quarter | 2024 Q4Oct 2024 | 2025 Q1Jan 2025 | 2025 Q2Apr 2025 | 2025 Q3Jul 2025 | 2025 Q4Oct 2025 | 2026 Q1Jan 2026 | 2026 Q2Apr 2026 | 2026 Q3Jul 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 481 | 431 | 221 | 362 | 545 | 268 | 277 | 519 |
| Depreciation and amortisation | 69 | 72 | 73 | 72 | 71 | 67 | 67 | 66 |
| Stock-based pay | 26 | 40 | 30 | 32 | 26 | 41 | 34 | 31 |
| Capital spending | 93 | 97 | 114 | 103 | 93 | 93 | 76 | 80 |
| Free cash flow | 388 | 334 | 107 | 259 | 452 | 175 | 201 | 439 |
| Free cash flow after stock pay | 362 | 294 | 77 | 227 | 426 | 134 | 167 | 408 |
Compare with peers
More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies